Latest News of RYTM
Rhythm Pharmaceuticals Inc (RYTM) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and ...
By Yahoo! Finance |
2 weeks ago
To advance a Daybreak trial population to a pivotal study, understanding genetic variants is crucial. Real-world data from French HO patients predicts positive Phase 3 outcomes. International market g...
Rhythm Pharmaceuticals, Inc. (RYTM): Short Seller Sentiment is Bearish
By Yahoo! Finance |
2 months ago
The US Federal Reserve cutting cycle signals a new investment era amid record-high stock indices. Concerns about a slowing economy prompt interest rate cuts, impacting consumer purchasing power and va...
Rhythm Pharmaceuticals, Inc. (RYTM) Stock Price, News, Quote & History - Yahoo Finance
By Yahoo! Finance |
2 months ago
Rhythm Pharmaceuticals' application for expanding the use of IMCIVREE (setmelanotide) to treat children as young as 2 with Bardet-Biedl syndrome or POMC/LEPR deficiency has been accepted for priority ...